Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
motivated candidates for a postdoctoral research position to develop and characterize carbon materials, such as natural graphite, porous carbon and hard carbon, intended for energy storage applications
-
particularly valuable. Documented experience in materials characterization, such as NMR spectroscopy, mass spectrometry, X-ray diffraction, X-ray photoelectron spectroscopy, vibrational spectroscopy, and
-
rocks. Special focus is put on Critical Raw Material (CRM, incl. e.g. REE, W, V) mobilization in the environment. The research group has a strong experimental and applied profile, with well-equipped
-
materials. The work may include development and application of AI-based protein design methods, experimental characterization of designed proteins, microbial engineering, biofilm design, and high-throughput
-
electrode and electrolyte materials, characterize them, evaluate and improve them with respect to battery performance, and study fundamental chemical processes and properties using both experimental and
-
-cell lymphomas. The research group conducts experimental and translational studies using clinically well-characterized patient material in close collaboration with clinical researchers. The research aims
-
crystals of inorganic molecular solids, extend the materials family and find better synthesis routes to it. Lead experiments in advanced materials characterization, including variable-temperature diffraction
-
clinically well-characterized patient material in close collaboration with clinical researchers. The research aims to improve the biological understanding of lymphoma by characterizing tumor cells, immune
-
at the Division of Chemical Engineering. The dairy group conducts research and education in dairy technology and dairy processes, with a focus on milk quality and how raw material and process conditions affect the
-
(Woll et al., Cancer Cell 2014; Chin et al., Blood 2022). Using uniquely biobanked and serially collected hematopoietic material from patients with leukemia we have demonstrated leukemic stem cell